Skip to main content
. 2021 Dec 16;9(12):1490. doi: 10.3390/vaccines9121490

Figure 4.

Figure 4

Schematic representation of the production and purification process during manufacturing of Virus-like Particles (VLPs), shows (A) the manufacturing process of VLPs and (B) their expression in cell systems.